Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,622 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06470191RecruitingPhase 2/Phase 3
B007 for primary membranous nephropathy
This trial tests a new drug called B007 for people with primary membranous nephropathy, a kidney condition. It aims to see if B007 can help reduce protein in the urine and protect kidney function.
BeijingAges 18–80 - NCT06737731RecruitingPhase 1/Phase 2
SHR-1681 for advanced solid tumors that have stopped responding to treatment
This trial tests a new drug called SHR-1681 in people with advanced solid tumors that have not responded to standard treatments or for which no standard treatment exists. The goal is to see if it can shrink tumors or slow their growth.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07622277Recruiting
Teeth Alignment Stability After Braces: A Retention Study
This study compares how different face types maintain their bite after orthodontic braces are removed. Researchers will use 3D imaging to track whether teeth stay in their corrected positions during the retention phase (when you wear retainers).
Rohtak, HaryanaAges 18–45 - NCT06723041Recruiting
Acupressure to lower anxiety during cancer treatment
This trial tests if acupressure—a gentle pressure technique on specific points—can help reduce anxiety in people receiving cancer therapy. It compares nurse-led acupressure sessions with learning self-administered acupressure.
Rochester, MinnesotaAges 18 years+ - NCT07135128RecruitingPhase 1
Study of a radioactive drug for advanced solid tumors
This trial tests a new radioactive drug (225Ac-FAPI-XT) for people with advanced solid tumors that have stopped responding to standard treatments. It targets a protein called FAP found on many cancer cells, which may help deliver radiation directly to the tumor.
Jinan, ShandongAges 18 years+ - NCT06714695Recruiting
Testing a mouthwash for black stains on kids' teeth
This trial tests if a special mouthwash made from chitosan (a natural substance from shellfish) can prevent black stains from coming back on children's teeth. Kids will use the mouthwash and be checked over 18 weeks to see if it works.
Cairo, Cairo GovernorateAges 6–12 - NCT06695689RecruitingEarly Phase 1
LM303 injection for advanced solid tumors
This trial tests an investigational treatment called LM303 for people with advanced solid tumors like melanoma, lung cancer, or cervical cancer. It uses your own immune cells (called TILs) to fight the cancer, so you need a tumor large enough for cells to be collected.
TianjinAges 18 years+ - NCT06712459Recruiting
Study of transformed splenic marginal zone lymphoma genetics
This study looks at tissue samples from people who have a more aggressive form of splenic marginal zone lymphoma. It aims to better understand the genetic changes that happen when the disease transforms, which may help doctors predict and treat this condition in the future.
New York, New YorkAges 18 years+ - NCT06711081Recruiting
Laser and cold therapy for painful back tooth
This study tests whether using a low-level laser and cold therapy together helps heal a back tooth that has deep decay and is causing severe pain. The goal is to save the tooth and avoid a root canal.
TantaAges 15–60 - NCT06712147Recruiting
MHE3: health study for Hispanic residents
This study tests ways to help Hispanic/Latino families overcome health obstacles. You may join if you live in certain San Jose zip codes.
Palo Alto, CaliforniaAges 18–65 - NCT06697691Recruiting
Predicting rebleeding risk after upper gut bleeding
This study aims to create a tool that helps doctors predict if a patient with upper gut bleeding (not from veins) will rebleed while still in the hospital. It uses information from your hospital stay to better understand your risk and improve care.
Wuhan, HubeiAges 18 years+ - NCT07547215Recruiting
TRAQ Minimally Invasive Sacroiliac Joint Fusion Study
This study tests a minimally invasive surgical procedure called TRAQ to treat chronic sacroiliac joint (SIJ) pain—a type of lower back and buttock pain. The procedure may help if you've had pain for at least 6 months that didn't improve with non-surgical treatments and have already benefited from diagnostic joint injections.
Tucson, ArizonaAges 21 years+ - NCT06175884Recruiting
Communication skills for chronic muscle and joint pain
This trial tests how a physical therapist's communication style affects pain and function in people with long-term muscle or joint pain. Participants will fill out questionnaires and watch a video to see if better communication improves outcomes.
LamiaAges 18–65 - NCT05924087Recruiting
Treatment study for narrowing of the windpipe after tracheotomy
This trial tests an interventional treatment for narrowing of the windpipe (tracheal stenosis) that happened after a percutaneous (through-skin) tracheotomy. It may help improve breathing and reduce problems caused by the narrowing.
NiddaAges 18 years+ - NCT07269717RecruitingPhase 2
Testing HRS-1893 for heart failure with preserved ejection fraction
This trial tests a new drug called HRS-1893 for people with heart failure with preserved ejection fraction (HFpEF). It aims to see if the drug can improve symptoms and quality of life.
Shanghai, Shanghai MunicipalityAges 40 years+ - NCT07346378Recruiting
Brain stimulation for post-stroke aphasia
This study tests a new type of brain stimulation called temporal interference stimulation to see if it can safely help people recover language abilities after a stroke. It aims to improve communication for people with post-stroke aphasia.
Hefei, AnhuiAges 18–80 - NCT05953350RecruitingPhase 1/Phase 2
Hydroxychloroquine plus CDK4/6 medicine for advanced solid tumors
This trial tests whether adding hydroxychloroquine (a medicine that affects a cell recycling process called autophagy) can boost the anti-cancer effect of high-dose CDK4/6 inhibitor treatment in advanced solid tumors. It may help tumors respond better after prior CDK4/6 treatments have stopped working.
Guangzhou, GuangdongAges 18 years+ - NCT06690203Enrolling by invitation
Herbal Medicine for Chronic Lung Conditions (NRICM102)
This trial tests an herbal medicine called NRICM102 for people with chronic cough and long-term lung diseases like asthma or COPD. It aims to see if the medicine is safe and helps improve symptoms.
Taichung, No.1650, Taiwan Boulevard Sect. 4Ages 18 years+ - NCT06658353RecruitingPhase 3
Study of VC004 for advanced solid tumors
This trial tests a new drug called VC004 for people with advanced solid tumors that have spread. It aims to see if the drug can shrink tumors or slow their growth.
Beijing, Beijing MunicipalityAges 12 years+ - NCT06640010Recruiting
Studying why cancer treatments cause side effects
This study uses special cells grown in a lab to understand why some cancer treatments cause side effects. It may help researchers find ways to predict and prevent these side effects in the future.
Jacksonville, FloridaAges 18 years+ - NCT06639074RecruitingPhase 2
Folate receptor dendritic cell vaccine for ovarian cancer
This trial tests a personalized vaccine made from your own immune cells, designed to target a protein called folate receptor alpha found on many ovarian cancer cells. It is for people who have finished initial chemotherapy and have no signs of cancer remaining, to try to prevent it from coming back.
Scottsdale, ArizonaAges 18 years+ - NCT06634147Recruiting
Exercise program to prevent decline in hospitalized older adults
This study is testing a gentle exercise program for older adults (75+) while they are in the hospital. The goal is to see if it helps prevent loss of strength, memory, or thinking skills.
Pamplona, NavarreAges 75 years+ - NCT05943197Recruiting
Microbiology-focused choice of joint prosthetic material
This trial focuses on using lab testing (microbiology) to help choose the best material for a prosthetic used in orthopedic treatment. If you need a prosthetic, this could help doctors select a material more tailored to your situation.
SamaraAges 1 month–1 month - NCT07652125Recruiting
RGL-270 vaccine plus immunotherapy for advanced lung cancer
This trial tests a new cancer vaccine (RGL-270) combined with immunotherapy drugs for advanced non-small cell lung cancer. The vaccine is designed to train your immune system to recognize and fight your specific cancer.
Guangzhou, Other (Non U.s.)Ages 18 years+
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,622 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.